- Abstract
3
- 10.1186/1753-6561-8-s4-o7
HPV vaccines in Brazil and the world
- Oct 01, 2014
- BMC Proceedings
- Luisa Villa
HPV vaccines in Brazil and the world
Virtually all women who have cervical cancer are infected with the human papillomavirus (HPV). Of the 275,000 women who die from cervical cancer every year, 88% live in developing countries. Two vaccines against the HPV have been approved. However, vaccine implementation in low-income countries tends to lag behind implementation in high-income countries by 15 to 20 years. In 2011, Rwanda's Ministry of Health partnered with Merck to offer the Gardasil HPV vaccine to all girls of appropriate age. The Ministry formed a "public-private community partnership" to ensure effective and equitable delivery. Thanks to a strong national focus on health systems strengthening, more than 90% of all Rwandan infants aged 12-23 months receive all basic immunizations recommended by the World Health Organization. In 2011, Rwanda's HPV vaccination programme achieved 93.23% coverage after the first three-dose course of vaccination among girls in grade six. This was made possible through school-based vaccination and community involvement in identifying girls absent from or not enrolled in school. A nationwide sensitization campaign preceded delivery of the first dose. Through a series of innovative partnerships, Rwanda reduced the historical two-decade gap in vaccine introduction between high- and low-income countries to just five years. High coverage rates were achieved due to a delivery strategy that built on Rwanda's strong vaccination system and human resources framework. Following the GAVI Alliance's decision to begin financing HPV vaccination, Rwanda's example should motivate other countries to explore universal HPV vaccine coverage, although implementation must be tailored to the local context.
Loading PDF
HPV vaccines in Brazil and the world
HPV vaccines in Brazil and the world
Health Care Provider Perceptions of Facilitators and Barriers to Human Papillomavirus Vaccination Delivery in Five Countries.
National human papillomavirus (HPV) vaccination programs could reduce global cervical cancer morbidity and mortality with support from health care providers. We assessed providers' perceptions of HPV vaccination in 5 countries. We identified providers from 5 countries where national HPV vaccination programs were at various stages of implementation: Argentina, Malaysia, South Africa, South Korea, and Spain. Providers authorized to administer adolescent vaccines completed an in-depth survey, reporting perceptions of barriers and facilitators to initiating and completing HPV vaccination, and logistical challenges to HPV vaccination. Among 151 providers, common barriers to HPV vaccination initiation across all countries were parents' lack of awareness (39%), concerns about vaccine safety or efficacy (33%), and cost to patients (30%). Vaccination education campaign (70%) was the most commonly cited facilitator of HPV vaccination initiation. Common barriers to series completion included no reminder system or dosing schedule (37%), loss to follow-up or forgetting appointment (29%), and cost to patients (25%). Cited facilitators to completing the vaccine series were education campaigns (45%), affordable vaccination (32%), and reminder/recall systems (22%). Among all countries, high cost of vaccination was the most common logistical challenge to offering vaccination to adolescents (33%). Incorporating provider insights into future HPV vaccination programs could accelerate vaccine delivery to increase HPV vaccination rates globally.
Read moreImmune Response 2019 : Factors influencing intention to obtain the HPV vaccine among a population of universitywomen in morocco - Dr. Aicha yacouti â University of Hassan
Immune Response 2019 : Factors influencing intention to obtain the HPV vaccine among a population of universitywomen in morocco - Dr. Aicha yacouti â University of Hassan
Read moreKnowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium
To test the knowledge of women, attending a gynecology clinic, on HPV, cervix cancer awareness and the knowledge and willingness to use HPV vaccine for themselves or their children. Routine gynecological and obstetrical care with ambulatory service in a medium-sized general hospital in a small town in Belgium (Heilig Hart Hospital, Tienen). Questionnaire to be filled out by 381 consecutive women while in the attendance room for consultation with one of the four gynecologists. Fisher T or Chi(2) were used as statistical methods. Knowledge about HPV as a cause of cervix cancer and the existence of a vaccine was roughly 50%. Women with lower education were more likely to know nothing about the cause of cervix cancer than women with higher education (54 versus 39%, P = 0.016). Half of the women were willing to accept the vaccine, whatever the cost price, and 40% required more information or refunding. Compared to women above 40, young age (25 years or less) was a risk factor for poor knowledge of HPV (P = 0.007), cervix cancer (P = 0.016) and the HPV vaccine (P = 0.07), regardless of a higher degree of education (79% postgraduate degree versus 43.4% in the 40+-year-old women, P = 0.006). Women with a daughter (64.7%) or a son (69.2%) were more inclined to vaccinate their daughter than women without children (46.3%, P < 0.0001). None of the women declined the vaccination because it was meant to protect against a sexually transmitted disease (STD). Upon introduction and marketing of the first HPV vaccine, only 50% of women attending a routine gynecology clinic were aware of the role of HPV in cervix cancer and the possibility of getting a vaccination against it. Unexpectedly, despite a high degree of education, young women seem to have a low awareness of cervix cancer, its cause and the preventive measures. Contrary to some women in the USA, Western European women are less likely to decline the HPV vaccine because it will protect them against STD. In Belgium, women who are childless or poorly educated and especially young women should be the targets of campaigns that motivate them to prevent HPV-induced cervix cancer.
Read moreKnowledge, Attitude, and Practice of Cervical Cancer Screening, and HPV Vaccination: A Cross-Sectional Study Among Obstetricians and Gynecologists in Egypt.
Although cervical cancer is potentially preventable, lack of knowledge and poor attitude among healthcare professionals toward cervical cancer screening and Human Papilloma Virus (HPV) vaccination can result in underutilization of these preventive strategies. Then, the objective of this study was to assess the knowledge, attitude, and practice of cervical cancer and its prevention through Pap test screening and HPV vaccination among obstetricians and gynecologists (Ob-Gyns). A cross-sectional study was conducted on 250 Egyptian attendees of a national Ob-Gyns professional conference. Data collection was performed using a pre-designed self-administered questionnaire, which tested participants' knowledge, attitude, and practices related to cervical cancer, Pap test screening, and HPV vaccination. The study included 41.2% Ob-Gyns specialists and 37.6% of consultants from secondary and tertiary care hospitals or centers. About 45% of participants had poor-to-fair knowledge, 57% had negative-to-fair positive attitudes toward cervical cancer screening and HPV vaccination, and 44% had ever-performed Pap test, while 45% of participants had ever-prescribed the HPV vaccine to their patients. Physicians' knowledge and attitude were significantly associated with their age, professional level, work experience, and place of work. Although performing cervical cancer screening was significantly more common among older, more experienced, and highly professional participants, HPV vaccine prescription was associated with young, less experienced participants at lower educational and professional levels. Ob-Gyns had poor-to-fair knowledge, Attitude, and practices related to cervical cancer, Pap test screening, and HPV vaccination.
Read morePrevention of Cervical Cancer: Era of HPV Testing and Vaccination
The incidence and mortality of cervical cancer in young women of reproductive ages have recently increased, which is a serious issue worldwide. This chapter will focus on the prevention of cervical cancer with HPV testing and vaccination. It is recognized that strategies for preventing cervical cancer consist of two major steps: preventing infection of oncogenic human papillomavirus (HPV)-16 and HPV-18 by HPV vaccination and secondary prevention by screening using HPV testing and/or cytology. Current cervical cancer screening strategies using cytology combined with HPV testing have been successfully introduced, with shifting from cytology alone to cytology plus HPV cotesting and now to a new paradigm in which HPV testing alone may become a primary screening tool. HPV vaccination is a “primary prevention” tool, and both the bivalent and quadrivalent HPV vaccines have excellent safety and efficacy profiles. Recently, a 9-valent vaccine, targeted against HPV-6, HPV-11, HPV-16, HPV-18, HPV-31, HPV-33, HPV-45, HPV-52, and HPV-58, has been developed, which may possibly protect against over 80% of invasive cervical cancers. Further evidence on the 9-valent HPV vaccine should be accumulated worldwide, and its application is expected as a new strategy. Finally, the WHO recognizes the prevention of cervical cancer and other HPV-related diseases as global public health problems and strongly recommends the HPV vaccination programs. Both HPV vaccination and cancer screening tests are indispensable for cervical cancer prevention. The complete eradication of this malignant disease in the world will be realized in the near future by the further development and widespread application of these two strategies.
Read moreAuthor's Response: HPV vaccination in India
The Indian government is quite correct not to prioritize HPV vaccination as a public health priority
Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali
Although screening for pre-cancerous cervical lesions and human papilloma virus (HPV) vaccination are accepted and effective means to prevent cervical cancer, women in Mali have limited access to these interventions. In addition, cervical cancer prevention by HPV vaccination has been controversial in some settings. To reduce cervical cancer prevalence and increase HPV vaccine uptake, it is important to understand the level of knowledge about cervical cancer screening and practices related to vaccination in at-risk populations. In this study, the level of knowledge about HPV and cervical cancer and attitudes towards vaccination were assessed among 301 participants (male and female, adults and adolescents) in a house-to-house survey in two urban neighborhoods in Bamako, Mali. The survey was combined with a brief educational session on HPV. Prior to the education session, overall knowledge of HPV infection and cervical cancer was very low: only 8% knew that HPV is a sexually transmitted infection (STI). Less than 20% of women had ever consulted a gynecologist and less than 3% had ever had cervical cancer screening. After hearing a description of HPV vaccine, more than 80% would accept HPV vaccination; fathers and husbands were identified as primary decisions makers and local clinics or the home as preferred sites for vaccination. This study provides information on STI knowledge and vaccine acceptance in Bamako, Mali in 2012, prior to the introduction of HPV vaccination.
Read moreParental acceptance of human papillomavirus (HPV) vaccination in Indonesia: A cross-sectional study
Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: A cross-sectional study
Abstract 1032: Knowledge, attitude and practices regarding human papillomavirus (HPV) and HPV vaccination among medical undergraduate students in Delhi: A cross-sectional study
Introduction: Human papillomavirus (HPV), a prevalent sexually transmitted infection, is a leading cause of cervical cancer, with high-risk strains such as HPV 16 and 18 contributing significantly to disease burden. Globally, cervical cancer is the fourth most common cancer in women, while in India, it ranks third, with an incidence rate of 18.3% (123, 907 cases) and a mortality rate of 9.1% (GLOBOCAN, 2020). Previous studies have highlighted significant gaps in knowledge, attitudes, and practices related to HPV and its vaccine. Furthermore, evidence indicates that targeted educational interventions can significantly enhance vaccine uptake and empower students to serve as effective advocates for vaccination. Objectives: This study aims to assess medical undergraduate students' knowledge about HPV and its vaccine, their vaccination status, and their attitudes towards HPV vaccination. Methodology: A cross-sectional study was performed at a medical college attached to a tertiary care hospital (Maulana Azad Medical College), Delhi, India. A total of 415 medical undergraduate students were enrolled via systematic random sampling. These participants were interviewed using a self-designed, pretested, semi-structured questionnaire including sections on sociodemographic data, knowledge about HPV and its vaccination, attitude toward the vaccine and actual vaccination practices among the study participants. Data was collected using Epicollect5 software. Data analysis was done using SAS software. Associations using Chi-square test (p&lt;0.05). Results: The mean age of participants was 21 years (SD = 1.74), ranging from 18 to 27 years. Of the 415 participants, 46.5% (n = 193) were female, and 53.5% (n = 222) were male, with most from an upper-middle socioeconomic background. The mean knowledge scores for HPV vaccination and cervical cancer were 10.77 (SD = 4.10) out of 20 and 12.28 (SD = 3.47) out of 25, respectively. While two-thirds demonstrated adequate knowledge about cervical cancer, awareness of its causal link to HPV was limited. The mean attitude score was 41.59 (SD = 4.93) out of 50, reflecting a generally positive outlook, though concerns about side effects, cost, and cultural acceptance persisted. Only 12.5% (n = 52) were vaccinated, with lack of awareness, cost, and perceived lack of need as key barriers. Notably, 60% expressed willingness to vaccinate if provided at subsidized rates or through university health programs. Conclusion: The study highlights both opportunities and challenges in promoting HPV vaccination among medical undergraduates in Delhi. Despite positive knowledge and attitudes, vaccination uptake was low. Most students expressed willingness to vaccinate if offered at a subsidized cost or through accessible programs, suggesting cost-effective strategies and institutional support could improve coverage. Citation Format: Srishty Srishty, Rajesh Kumar, Bratati Banerjee, Amod Laxmikant Borle, Aseem Aseem. Knowledge, attitude and practices regarding human papillomavirus (HPV) and HPV vaccination among medical undergraduate students in Delhi: A cross-sectional study [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 1032.
Read moreHuman papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda.
Cervical cancer is responsible for one-quarter of a million deaths per year worldwide. In South Africa (SA), cervical cancer is the leading cause of cancer deaths among women aged 15 - 44 years. Human papillomavirus (HPV) vaccines provide a safe and highly effective means to reduce the burden of cervical cancer. The World Health Organization initiated a plan for the elimination of cervical cancer; the programme's success relies on the introduction and high uptake of HPV vaccines globally. SA introduced a school-based HPV vaccination programme in 2014, but uptake is not as high as expected. Suboptimal HPV vaccination coverage may result from various factors, including vaccine hesitancy. Vaccine-hesitant parents may delay or refuse HPV vaccination for their daughters. Tailored interventions are needed to address this. However, knowledge regarding vaccine hesitancy and policies to address this hesitancy in SA are currently limited. While SA has taken commendable steps in cervical cancer prevention by implementing and financing the HPV vaccination programme, it is imperative that there are clear policies in place to help strengthen the programme. These policies need to clarify areas of uncertainty that may lead to mistrust, and pre-empt factors that will cause hesitancy. Equally important is that local research should be conducted to better understand HPV vaccination hesitancy and other determinants of uptake to further inform and shape national policies.
Read moreQuestionnaires survey on the cognition of prevention and treatment for cervical lesions among females from Shenzhen communities
Objective The cognition of cervical cancer, Human Papillomavirus (HPV) and HPV vaccine among females from Shenzhen communities was studied, which provided a reference for prevention and treatment of cervical cancer. Methods The multi-stage sampling method was adopted to select 350 females from 10 communities. The questionnaire survey was conducted for understanding the awareness of cervical cancer, HPV and HPV vaccine related knowledge. Results Among 350 copies of questionnaires, 326 copies were actually effective with an effective rate of 93.14%.The awareness rates of HPV, HPV vaccine, cervical cancer etiology, high-risk HPV (main inducing cervical cancer), how to prevent cervical cancer, route of HPV infection and high-risk factors of HPV spreading were 47.24%(154/326), 30.06%(98/326), 48.47%(158/326), 20.6%(67/326), 21.8%(71/326), 21.2%(69/326). The awareness was significantly higher in the females who were in the age of 31-40 years old, with more than 30 thousand income, with college education or above degree, civil servants or office clerks (P<0.05). Conclusions The females from communities have some knowledge about the relationship between cervical cancer and HPV, but lack comprehensive understanding of prevention and treatment of cervical cancer. Especially we need to enhance the diverse health knowledge spread in females who are young, with low-education background, with low income and labors or farmers, improving the awareness rate of prevention and treatment for cervical lesions. Key words: Cervical lesions; Human papillomavirus (HPV); HPV vaccine; Awareness rate; Health education
Read moreAbstract D014: Assessing an intervention to increase cervical cancer knowledge and HPV vaccination knowledge among predominantly African American communities in South Carolina
BACKGROUND: Human papilloma virus (HPV) is linked to cervical cancer incidence. The HPV vaccine has been shown to significantly reduce the risk of HPV infection and subsequent cervical cancer diagnosis. Unfortunately, African Americans (AA) show lower uptake of the HPV vaccine than other groups. Underuse of the HPV vaccine has been linked to lack of knowledge of its effectiveness in preventing cervical cancer. OBJECTIVES: The purpose of this study was to evaluate an educational intervention to improve cervical cancer knowledge and HPV vaccine knowledge among predominantly AA communities in South Carolina (SC). METHODS: The study was conducted in a convenience sample of residents of five SC counties with high racial disparities in cervical cancer mortality rates that were recruited by community partners. The intervention consisted of a 4.5-hour educational session with 8 different components including a 30-minute cervical cancer/HPV vaccination knowledge component. Pre-and post- intervention surveys were administered. MEASURES: A 7-item investigator-developed instrument was used to evaluate pre-/post-intervention changes in cervical cancer knowledge and HPV vaccination knowledge. The items were based on the investigators’ review of the contemporary literature on the topics of cervical cancer, HPV infection, and the HPV vaccine. RESULTS: The first sample consisted of 64 participants from last year and this year participants consisted of 28 which make 92 in all (99% AA). Most of the participants who reported age were 50+ years. Among those who reported gender, 90% were female. Among those who reported income, 80% had an annual household income &gt;$40,000. Seventy-two percent of the participants who reported their educational level had received at least some college training. Conclusions: Providing cervical cancer and HPV vaccination information leads to increasing knowledge related to cervical cancer and the HPV vaccine. In the future study, the investigators will evaluate changes in the pre-/post-intervention. HPV vaccination uptake rates in the five counties where the intervention was conducted. Citation Format: Marvella E Ford, Kimberly Cannady, NiAsia Hazelton, Kendrea D Knight, Claudia Lawton, Angela M Malek, Judith D Salley. Assessing an intervention to increase cervical cancer knowledge and HPV vaccination knowledge among predominantly African American communities in South Carolina [abstract]. In: Proceedings of the Twelfth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2019 Sep 20-23; San Francisco, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl_2):Abstract nr D014.
Read moreEfficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis.
We conducted a meta-analysis to assess the efficacy of prophylactic human papillomavirus (HPV) vaccines against cervical cancer precursors and HPV persistent infection among Asian populations. Randomized controlled clinical trials conducted in Asian countries were identified from three electronic databases (PubMed, EMBASE and the Cochrane Library). Publication retrieval was performed on September 1, 2022 and only those written in English were included. The data were analyzed with Cochrane Review Manager (version 5.3) and Stata/SE (15.1). Effect sizes were presented as risk ratios (RRs) and 95% confidence intervals (CIs). Ten articles were considered in the meta-analysis, without significant heterogeneity among them. The fixed-effect RRs and 95% CIs for cervical intraepithelial neoplasia grade 1 (CIN1+) and CIN2+ were 0.10 (0.05-0.21) and 0.11 (0.04-0.27), respectively. Positive effect of HPV vaccination on 6- and 12-month persistent infection were observed, with the respective pooled RRs of 0.05 (95% CI: 0.03-0.09) and 0.09 (95% CI: 0.05-0.15). HPV vaccination has a positive effect on the incidence of cytological abnormalities associated with HPV 16/18 (RR, 0.13; 95% CI (0.09-0.20)). Positive effects of HPV vaccination were also observed for HPV 16- and 18-specific immunogenicity (RR, 235.02; 95% CI (82.77-667.31) and RR, 98.24; 95% CI (50.36-191.67), respectively). Females receiving an initial vaccination showed significant decreased incidences of cervical intraepithelial neoplasia, HPV persistent infection and cytological abnormalities and a significantly higher antibody positive conversion rate compared with non-vaccination counterparts. Prophylactic HPV vaccines are highly efficacious in preventing cervical cancer in Asian females. The government should accelerate the processes of vaccine introduction and vaccination implementation by prioritizing them in public health policies, which should be helpful to enhance Asian females' awareness of receiving HPV vaccination volitionally.
Read moreA study on the predictors of Korean male students' intention to receive human papillomavirus vaccination.
The objective was to survey the current state of human papillomavirus (HPV) vaccination and the predictors of vaccination intention among Korean male students of high school (ages 15-19) and university (ages 17-27). Human papillomavirus is a sexually transmitted infectious agent causing uterine cervical, anal, and/or penile cancer and genital warts in males and females. Infection rate of human papillomavirus increases from the age when sexual intercourse first occurs. Therefore, motivation to receive human papillomavirus vaccination is needed to protect infection. Cross-sectional descriptive survey was performed only in male students. They are less aware of human papillomavirus than females, because human papillomavirus vaccination has been targeted on females for preventing cervical cancer in Korea. Data were collected using a self-reporting questionnaire for male high school and university students sampled from a city in Korea. Human papillomavirus vaccine-related knowledge, health beliefs, demographic, and sexual history information variables relating to intentions to vaccinate were assessed. The human papillomavirus vaccination rate was very low and the levels of knowledge and health beliefs were low. The significant predictors that raised the intention of human papillomavirus vaccination were a university student, experience of sexual intercourse and perceiving the benefits of human papillomavirus vaccination. To promote human papillomavirus vaccination, educational programming targeting males should include health beliefs and knowledge, emphasising that vaccination is important to prevent uterine cervical cancer and to role as a preventative measure against common male diseases. Male high school students should be included as a major target population for school human papillomavirus education programmes, as they are at the age of commencing sexual intercourse. In addition, public health policies including human papillomavirus vaccination in the national immunisation programme are warranted.
Read more